A correction was issued regarding a p-value in a study comparing antituberculosis therapies for HIV-related sepsis in Tanzania and Uganda.
A correction has been made to the Lancet Infectious Diseases article regarding the study on immediate or high-dose antituberculosis therapy for HIV-related sepsis in Tanzania and Uganda. Specifically, the p-value in the Summary's Findings for patients with microbiologically confirmed tuberculosis, comparing the diagnosis-dependent high-dose group to the conventional-dose group, was incorrectly stated. The accurate p-value should be listed as 0·079. This correction is essential for the integrity of the research findings.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.
Personalise this feed
Your specialty. Your sources. Your digest.
All set up in under 2 minutes.